NIH to evaluate remdesivir treatment for COVID during pregnancy
Por um escritor misterioso
Descrição
WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]
Remdesivir against COVID-19 and Other Viral Diseases
IJERPH, Free Full-Text
Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial - The
Favipiravir, camostat, and ciclesonide combination therapy in
COVID-19 in people with rheumatic diseases: risks, outcomes
Clinical outcomes of hospitalized COVID-19 patients treated with
Pregnancy and COVID-19
2020 Archive - UM School of Medicine Researchers Test Remdesivir
Baricitinib in Combination with Remdesivir Reduces Time to
Frontiers Mortality Benefit of Remdesivir in COVID-19: A
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid
Mild or Moderate Covid-19
Remdesivir for the treatment of hospitalized patients with severe
de
por adulto (o preço varia de acordo com o tamanho do grupo)
